These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36282576)

  • 21. Comparison of the minimum inhibitory, mutant prevention and minimum bactericidal concentrations of ciprofloxacin, levofloxacin and garenoxacin against enteric Gram-negative urinary tract infection pathogens.
    Hansen GT; Blondeau JM
    J Chemother; 2005 Oct; 17(5):484-92. PubMed ID: 16323436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quinolone-associated tendonitis: a potential problem in COPD?
    Butler MW; Griffin JF; Quinlan WR; McDonnell TJ
    Ir J Med Sci; 2001; 170(3):198-9. PubMed ID: 12120977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ciprofloxacin-associated bilateral iliopsoas tendon rupture: a case report.
    Smith N; Fackrell R; Henderson E
    Age Ageing; 2016 Sep; 45(5):737-8. PubMed ID: 27220702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reoccurrence of levofloxacin-induced tendinitis by phenoxymethylpenicillin therapy after 6 months: a rare complication of fluoroquinolone therapy?
    Schindler C; Pittrow D; Kirch W
    Chemotherapy; 2003 May; 49(1-2):90-1. PubMed ID: 12756981
    [No Abstract]   [Full Text] [Related]  

  • 25. "Ciprofloxacin-induced" bilateral rectus femoris tendon rupture.
    Karistinos A; Paulos LE
    Clin J Sport Med; 2007 Sep; 17(5):406-7. PubMed ID: 17873557
    [No Abstract]   [Full Text] [Related]  

  • 26. Risks associated with the use of fluoroquinolones.
    DeLaney MC
    Br J Hosp Med (Lond); 2018 Oct; 79(10):552-555. PubMed ID: 30290736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adverse drug reactions related to the use of fluoroquinolone antimicrobials: an analysis of spontaneous reports and fluoroquinolone consumption data from three italian regions.
    Leone R; Venegoni M; Motola D; Moretti U; Piazzetta V; Cocci A; Resi D; Mozzo F; Velo G; Burzilleri L; Montanaro N; Conforti A
    Drug Saf; 2003; 26(2):109-20. PubMed ID: 12534327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluoroquinolone-induced tendinopathy: what do we know?
    Harrell RM
    South Med J; 1999 Jun; 92(6):622-5. PubMed ID: 10372859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluoroquinolone use in a rural practice.
    Kelly L; Schreiber YS; Hopko J; Kirkwood T; Kattini R; Poirier D; Madden S
    Can J Rural Med; 2021; 26(1):14-18. PubMed ID: 33380601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Levofloxacin. Its use in infections of the respiratory tract, skin, soft tissues and urinary tract.
    Langtry HD; Lamb HM
    Drugs; 1998 Sep; 56(3):487-515. PubMed ID: 9777318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ciprofloxacin-Induced Anaphylactic Reaction Followed by Negative Provocation Test in Response to Levofloxacin: A Case Report.
    Kurtov M; Kilić P; Ikić L; Kurtov K; Dorčić G; Vodanović M; Artuković M; Ikić Matijašević M
    Medicina (Kaunas); 2023 Oct; 59(10):. PubMed ID: 37893502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The expanding role of fluoroquinolones.
    Schaeffer AJ
    Am J Med; 2002 Jul; 113 Suppl 1A():45S-54S. PubMed ID: 12113871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ciprofloxacin, bilateral Achilles tendonitis and unilateral tendon rupture--a case report.
    West MB; Gow P
    N Z Med J; 1998 Jan; 111(1058):18-9. PubMed ID: 9484431
    [No Abstract]   [Full Text] [Related]  

  • 34. Fluoroquinolone-associated suspected tendonitis and tendon rupture: A pharmacovigilance analysis from 2016 to 2021 based on the FAERS database.
    Shu Y; Zhang Q; He X; Liu Y; Wu P; Chen L
    Front Pharmacol; 2022; 13():990241. PubMed ID: 36147351
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparison of sparfloxacin and ciprofloxacin in the treatment of community-acquired acute uncomplicated urinary tract infection in women. Sparfloxacin Multicenter Uncomplicated Urinary Tract Infection Study Group.
    Henry DC; Nenad RC; Iravani A; Tice AD; Mansfield DL; Magner DJ; Dorr MB; Talbot GH
    Clin Ther; 1999 Jun; 21(6):966-81. PubMed ID: 10440621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recurrent tendinitis after treatment with two different fluoroquinolones.
    Burkhardt O; Köhnlein T; Pap T; Welte T
    Scand J Infect Dis; 2004; 36(4):315-6. PubMed ID: 15198194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tendon Injury and Fluoroquinolone Use: A Systematic Review.
    Stephenson AL; Wu W; Cortes D; Rochon PA
    Drug Saf; 2013 Sep; 36(9):709-21. PubMed ID: 23888427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Use of fluoroquinolones in nursing homes].
    Fagan M; Skotheim SB
    Tidsskr Nor Laegeforen; 2010 Oct; 130(20):2022-4. PubMed ID: 20967041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Fluoroquinolones as etiology of tendinopathy].
    Gabutti L; Stoller R; Marti HP
    Ther Umsch; 1998 Sep; 55(9):558-61. PubMed ID: 9789471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluoroquinolones and the Risk of Achilles Tendon Disorders: Update on a Neglected Complication.
    Godoy-Santos AL; Bruschini H; Cury J; Srougi M; de Cesar-Netto C; Fonseca LF; Maffulli N
    Urology; 2018 Mar; 113():20-25. PubMed ID: 29074337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.